A retrospective study of cardiovascular events related to the use of Glucose lowering drug treatment in Primary Care - ROSE

To describe the type II diabetes population in primary care with special reference to treatment, other diseases and mortality during the last decade. To test the hypothesis that the type or combination of per oral glucose lowering drugs have different effects on the risk of cardiovascular disease and diabetic complications.